Live feed
Filing
SC 13D/A
SC 13D/A0001493152-21-006313·Gene Biotherapeutics, Inc.
Schedule 13D ownership disclosure
Gene Biotherapeutics, Inc.
Security class unavailable · CUSIP: 867671041
Event date: 2021-03-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,000,000
- Percent of class
- 27.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-21-006313
- Form type
- SC 13D/A
- Filer
- Gene Biotherapeutics, Inc.
- CIK
- CIK 772320
- Filed
- Mar 18, 2021
- Reporting period
- Mar 16, 2021
- Description
- Schedule 13D beneficial ownership